Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    cas:835621-07-3;Regorafenib hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 8,844Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    Looking for 755037-03-7 / Regorafenib API manufacturers, exporters & distributors?

    Regorafenib manufacturers, exporters & distributors 1

    36

    PharmaCompass offers a list of Regorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regorafenib manufacturer or Regorafenib supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regorafenib manufacturer or Regorafenib supplier.

    PharmaCompass also assists you with knowing the Regorafenib API Price utilized in the formulation of products. Regorafenib API Price is not always fixed or binding as the Regorafenib Price is obtained through a variety of data sources. The Regorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Regorafenib

    Synonyms

    755037-03-7, Bay 73-4506, Stivarga, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-n-methylpicolinamide, Regorafenibum, Regorafenib (bay 73-4506)

    Cas Number

    755037-03-7

    Unique Ingredient Identifier (UNII)

    24T2A1DOYB

    About Regorafenib

    Regorafenib is the anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.

    cas:835621-07-3;Regorafenib hydrochloride Manufacturers

    A cas:835621-07-3;Regorafenib hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of cas:835621-07-3;Regorafenib hydrochloride, including repackagers and relabelers. The FDA regulates cas:835621-07-3;Regorafenib hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. cas:835621-07-3;Regorafenib hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of cas:835621-07-3;Regorafenib hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    cas:835621-07-3;Regorafenib hydrochloride Suppliers

    A cas:835621-07-3;Regorafenib hydrochloride supplier is an individual or a company that provides cas:835621-07-3;Regorafenib hydrochloride active pharmaceutical ingredient (API) or cas:835621-07-3;Regorafenib hydrochloride finished formulations upon request. The cas:835621-07-3;Regorafenib hydrochloride suppliers may include cas:835621-07-3;Regorafenib hydrochloride API manufacturers, exporters, distributors and traders.

    click here to find a list of cas:835621-07-3;Regorafenib hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    cas:835621-07-3;Regorafenib hydrochloride CEP

    A cas:835621-07-3;Regorafenib hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a cas:835621-07-3;Regorafenib hydrochloride Certificate of Suitability (COS). The purpose of a cas:835621-07-3;Regorafenib hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of cas:835621-07-3;Regorafenib hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of cas:835621-07-3;Regorafenib hydrochloride to their clients by showing that a cas:835621-07-3;Regorafenib hydrochloride CEP has been issued for it. The manufacturer submits a cas:835621-07-3;Regorafenib hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a cas:835621-07-3;Regorafenib hydrochloride CEP holder for the record. Additionally, the data presented in the cas:835621-07-3;Regorafenib hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the cas:835621-07-3;Regorafenib hydrochloride DMF.

    A cas:835621-07-3;Regorafenib hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. cas:835621-07-3;Regorafenib hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of cas:835621-07-3;Regorafenib hydrochloride suppliers with CEP (COS) on PharmaCompass.

    cas:835621-07-3;Regorafenib hydrochloride Manufacturers | Traders | Suppliers

    cas:835621-07-3;Regorafenib hydrochloride Manufacturers, Traders, Suppliers 1
    91

    We have 1 companies offering cas:835621-07-3;Regorafenib hydrochloride

    Get in contact with the supplier of your choice:

    1. MSN Laboratories
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.